| Literature DB >> 28361983 |
Ji-Yeon Yang1, Jun-Hwan Park1, Namhyun Chung2, Hoi-Seon Lee1.
Abstract
Inhibition of α-amylase and α-glucosidase, advanced glycation end products (AGEs) formation, and oxidative stress by isolated active constituents of Osmanthus fragrans flowers (9,12-octadecadienoic acid and 4-(2,6,6-trimethyl-1-cyclohexenyl)-3-buten-2-one) and their structural analogues were evaluated. 9,12-Octadecadienoic acid was 10.02 and 22.21 times more active against α-amylase and α-glucosidase, respectively, than acarbose and ascorbic acid, followed by 9,12,15-octadecatrienoic acid, 9-octadecenoic acid, 4-(2,6,6-trimethyl-1-cyclohexenyl)-3-buten-2-one, 4-(2,6,6-trimethyl-2-cyclohexenyl)-3-buten-2-one, 1-heptadecanecarboxylic acid, and 1-pentadecanecarboxylic acid. Concerning the inhibition of AGEs formation, similar with data for 2,2'-diphenyl-1-picrylhydrazl radical scavenging activities, 9,12-octadecadienoic acid was 3.54 times more active than aminoguanidine, followed by 9,12,15-octadecatrienoic acid, and 9-octadecenoic acid. These results indicate that 4-(2,6,6-trimethyl-1-cyclohexenyl)-3-buten-2-one, 9,12-octadecadienoic acid and their analogues inhibit α-amylase and α-glucosidase, AGEs formation, and oxidative stress have potential value in alleviating diabetic pathological conditions.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28361983 PMCID: PMC5374635 DOI: 10.1038/srep45746
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
IC50 values of five fractions partitioned from the methanol extract of O. fragrans.
| Materials | IC50 values (μg/ml, means ± SE) | |||
|---|---|---|---|---|
| AGE | α–Amylase | DPPH | α–Glucosidase | |
| Methanol extract | 185.8 ± 1.6 | 275.6 ± 2.1 | 69.8 ± 2.0 | 134.5 ± 1.9 |
| Hexane fraction | 152.8 ± 1.8 | 250.2 ± 2.1 | 62.5 ± 1.4 | 120.4 ± 2.3 |
| Chloroform fraction | 110.5 ± 2.5 | 134.5 ± 1.7 | 60.7 ± 2.1 | 60.5 ± 1.6 |
| Ethyl acetate fraction | 258.8 ± 1.7 | 290.4 ± 1.9 | 75.2 ± 0.5 | 143.5 ± 2.1 |
| Butanol fraction | >500 | 325.5 ± 1.2 | 76.4 ± 0.6 | 184.3 ± 2.3 |
| Distilled water fraction | >500 | 0 | 129.8 ± 1.2 | 0 |
| Acarbose | 158.4 ± 1.4 | 75.5 ± 1.8 | ||
| Ascorbic acid | 25.5 ± 0.4 | |||
| Aminoguanidine | 54.5 ± 0.7 | |||
Acarbose was used as the positive control for α–glucosidase and α–amylase. Ascorbic acid was the positive control for DPPH. Aminoguanidine was the positive control for the inhibition of AGEs formation.
Figure 1Lineweaver–Burk plot of the inhibition kinetics against α–glucosidase (a) and α–amylase (b) by the chloroform subfraction subdivided of the methanol extract of O. fragrans.
1H- and 13C-NMR spectra of OF12.
| Carbon | Partial structure | δC (ppm) | δH (ppm) |
|---|---|---|---|
| 1 | COOH | 182.56 | 9.18 (s) |
| 2 | C-2H | 36.39 | 4.25-4.29 (t, |
| 3 | C-2H | 26.99 | 3.22-3.28 (m, |
| 4 | C-2H | 31.36 | 3.22-3.28 (m, |
| 5 | C-2H | 31.41 | 3.22-3.28 (m, |
| 6 | C-2H | 31.68 | 3.22-3.28 (m, |
| 7 | C-2H | 31.92 | 3.22-3.28 (m, |
| 8 | C-2H | 29.54 | 3.94-4.00 (q, |
| 9 | C-H | 132.35 | 7.28-7.29 (q, |
| 10 | C-H | 130.24 | 7.28-7.29 (q, |
| 11 | C-2H | 27.97 | 4.68-4.71 (t, |
| 12 | C-H | 130.40 | 7.28-7.29 (q, |
| 13 | C-H | 132.54 | 7.28-7.29 (q, |
| 14 | C-2H | 29.51 | 3.94-4.00 (q, |
| 15 | C-2H | 31.47 | 3.22-3.28 (m, |
| 16 | C-2H | 33.86 | 3.22-3.28 (m, |
| 17 | C-2H | 24.90 | 3.22-3.28 (m, |
| 18 | C-3H | 16.39 | 2.79-2.83 (t, |
s, singlet; t, triplet; m, multilet; q, quartlet.
1H- and 13C-NMR spectra of OF453.
| Carbon | Partial structure | δC (ppm) | δH (ppm) |
|---|---|---|---|
| 1 | C-3H | 29.68 | 2.485 (s) |
| 2 | C | 201.24 | |
| 3 | C-H | 138.46 | 6.29-6.33 (d, |
| 4 | C-H | 145.68 | 2.25-2.28 (t, |
| 1’ | C-H | 42.26 | 7.45-7.48 (d, |
| 2’ | C | 138.57 | |
| C-3H | 21.40 | 1.95 (s) | |
| 3’ | C-H | 134.12 | 2.25-2.28 (t, |
| 4’ | C-2H | 31.32 | 1.79-1.83 (q, |
| 5’ | C-2H | 36.08 | 1.66-1.68 (t, |
| 6’ | C | 36.59 | |
| C-3H | 24.25 | 1.26 (s) |
s, singlet; d, doublet; t, triplet; q, quartlet.
IC50 values of isolated active constituents and their structural analogues.
| Chemicals | IC50 values (μg/ml, means ± SE) | |||
|---|---|---|---|---|
| AGE | α–Amylase | DPPH | α–Glucosidase | |
| 4-(2,6,6-Trimethyl-2-cyclohexenyl)-3-buten-2-one | 50.5 ± 1.8 | 87.2 ± 1.3 | 23.2 ± 2.5 | 33.2 ± 1.8 |
| 4-(2,6,6-Trimethyl-1-cyclohexenyl)-3-buten-2-one | 48.4 ± 2.3 | 84.4 ± 0.8 | 20.5 ± 1.5 | 31.5 ± 2.2 |
| 9,12-Octadecadienoic acid | 15.4 ± 1.8 | 15.8 ± 2.3 | 6.8 ± 1.2 | 3.4 ± 1.5 |
| 9,12,15-Octadecatrienoic acid | 18.2 ± 2.3 | 21.2 ± 3.6 | 7.4 ± 0.9 | 4.5 ± 2.4 |
| 9-Octadecenoic acid | 18.8 ± 1.1 | 23.5 ± 1.8 | 7.6 ± 1.5 | 4.8 ± 0.9 |
| 1-Heptadecanecarboxylic acid | 34.7 ± 2.6 | 140.5 ± 2.3 | 15.6 ± 2.2 | 46.2 ± 2.5 |
| 1-Pentadecanecarboxylic acid | 40.6 ± 0.7 | 168.2 ± 1.4 | 20.8 ± 1.3 | 55.4 ± 3.2 |
| 1-Tridecanecarboxylic acid | 51.2 ± 1.8 | 225.2 ± 2.3 | 24.5 ± 1.8 | 60.4 ± 1.2 |
| Acarbose | 158.4 ± 1.4 | 75.5 ± 1.8 | ||
| Ascorbic acid | 25.5 ± 0.4 | |||
| Aminoguanidine | 54.5 ± 0.7 | |||
Acarbose served as the positive control for α–glucosidase and α–amylase. Ascorbic acid was the positive control for DPPH. Aminoguanidine was the positive control for the inhibition of AGEs formation.
Figure 2Effects of 4-(2,6,6-trimethyl-1-cyclohexenyl)-3-buten-2-one and 9,12-octadecadienoic acid on blood glucose levels.
2.5 g/kg body weight, with 50 mg/kg with body weight 9,12-octadecadienoic acid (□), 4-(2,6,6-trimethyl-1-cyclohexenyl)-3-buten-2-one (△), and control (◇). Each point represents mean ± SD (n = 3).
Figure 3Chemical structures of 4-(2,6,6-trimethyl-1-cyclohexenyl)-3-buten-2-one and 9,12-octadecadienoic acid analogues.
(a) 4-(2,6,6-trimethyl-2-cyclohexenyl)-3-buten-2-one; (b) 4-(2,6,6-trimethyl-1-cyclohexenyl)-3-buten-2-one; (c) 9,12-octadecadienoic acid; (d) 9,12,15-octadecatrienoic acid; (e) 9-octadecenoic acid; (f) 1-heptadecanecarboxylic acid; (g) 1-pentadecanecarboxylic acid; (h) 1-tridecanecarboxylic acid.